RLAY logo

Relay Therapeutics, Inc. (RLAY) Net income

annual net income:

-$337.71M+$4.26M(+1.25%)
December 31, 2024

Summary

  • As of today (August 29, 2025), RLAY annual net profit is -$337.71 million, with the most recent change of +$4.26 million (+1.25%) on December 31, 2024.
  • During the last 3 years, RLAY annual net income has risen by +$26.16 million (+7.19%).
  • RLAY annual net income is now -592.24% below its all-time high of -$48.78 million, reached on December 31, 2018.

Performance

RLAY Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

quarterly net income:

-$70.38M+$6.69M(+8.68%)
June 30, 2025

Summary

  • As of today (August 29, 2025), RLAY quarterly net profit is -$70.38 million, with the most recent change of +$6.69 million (+8.68%) on June 30, 2025.
  • Over the past year, RLAY quarterly net income has increased by +$21.84 million (+23.68%).
  • RLAY quarterly net income is now -299.50% below its all-time high of $35.28 million, reached on December 31, 2020.

Performance

RLAY quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

TTM net income:

-$311.55M+$21.84M(+6.55%)
June 30, 2025

Summary

  • As of today (August 29, 2025), RLAY TTM net profit is -$311.55 million, with the most recent change of +$21.84 million (+6.55%) on June 30, 2025.
  • Over the past year, RLAY TTM net income has increased by +$11.28 million (+3.49%).
  • RLAY TTM net income is now -2096.79% below its all-time high of -$14.18 million, reached on March 31, 2019.

Performance

RLAY TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRLAYincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

RLAY Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.3%+23.7%+3.5%
3 y3 years+7.2%+8.3%-16.6%
5 y5 years-348.4%-163.3%-227.3%

RLAY Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.3%+7.2%-7.1%+28.6%-16.6%+9.8%
5 y5-year-544.3%+7.2%-299.5%+63.6%-494.4%+18.8%
alltimeall time-592.2%+7.2%-299.5%+63.6%-2096.8%+18.8%

RLAY Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$70.38M(-8.7%)
-$311.55M(-6.6%)
Mar 2025
-
-$77.06M(+1.4%)
-$333.39M(-1.3%)
Dec 2024
-$337.71M(-1.2%)
-$76.00M(-13.7%)
-$337.71M(-2.2%)
Sep 2024
-
-$88.11M(-4.5%)
-$345.20M(+6.9%)
Jun 2024
-
-$92.21M(+13.3%)
-$322.83M(-1.9%)
Mar 2024
-
-$81.39M(-2.5%)
-$329.12M(-3.8%)
Dec 2023
-$341.97M(+17.7%)
-$83.50M(+27.0%)
-$341.97M(+4.9%)
Sep 2023
-
-$65.73M(-33.3%)
-$325.98M(-5.4%)
Jun 2023
-
-$98.50M(+4.5%)
-$344.42M(+6.7%)
Mar 2023
-
-$94.24M(+39.6%)
-$322.70M(+11.1%)
Dec 2022
-$290.51M
-$67.50M(-19.8%)
-$290.51M(+0.0%)
Sep 2022
-
-$84.17M(+9.6%)
-$290.46M(+8.7%)
Jun 2022
-
-$76.79M(+23.8%)
-$267.12M(-30.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$62.05M(-8.0%)
-$383.73M(+5.5%)
Dec 2021
-$363.87M(+594.3%)
-$67.46M(+10.9%)
-$363.87M(+39.3%)
Sep 2021
-
-$60.83M(-68.5%)
-$261.14M(+10.5%)
Jun 2021
-
-$193.40M(+358.5%)
-$236.38M(+239.1%)
Mar 2021
-
-$42.18M(-219.6%)
-$69.71M(+33.0%)
Dec 2020
-$52.41M(-30.4%)
$35.28M(-197.8%)
-$52.41M(-53.0%)
Sep 2020
-
-$36.08M(+35.0%)
-$111.60M(+17.2%)
Jun 2020
-
-$26.72M(+7.4%)
-$95.20M(+10.7%)
Mar 2020
-
-$24.89M(+4.1%)
-$86.01M(+14.2%)
Dec 2019
-$75.31M(+54.4%)
-$23.91M(+21.6%)
-$75.31M(+46.5%)
Sep 2019
-
-$19.67M(+12.2%)
-$51.39M(+62.0%)
Jun 2019
-
-$17.54M(+23.7%)
-$31.72M(+123.7%)
Mar 2019
-
-$14.18M
-$14.18M
Dec 2018
-$48.78M
-
-

FAQ

  • What is Relay Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. annual net income year-on-year change?
  • What is Relay Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Relay Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Relay Therapeutics, Inc.?
  • What is Relay Therapeutics, Inc. TTM net income year-on-year change?

What is Relay Therapeutics, Inc. annual net profit?

The current annual net income of RLAY is -$337.71M

What is the all time high annual net income for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high annual net profit is -$48.78M

What is Relay Therapeutics, Inc. annual net income year-on-year change?

Over the past year, RLAY annual net profit has changed by +$4.26M (+1.25%)

What is Relay Therapeutics, Inc. quarterly net profit?

The current quarterly net income of RLAY is -$70.38M

What is the all time high quarterly net income for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high quarterly net profit is $35.28M

What is Relay Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, RLAY quarterly net profit has changed by +$21.84M (+23.68%)

What is Relay Therapeutics, Inc. TTM net profit?

The current TTM net income of RLAY is -$311.55M

What is the all time high TTM net income for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high TTM net profit is -$14.18M

What is Relay Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, RLAY TTM net profit has changed by +$11.28M (+3.49%)
On this page